Glenmark Life Sciences IPO Subscription Status
Glenmark Life Sciences IPO subscription to start from 27 July 2021 to 29 July 2021. The Initial Public offer of Equity Shares comprising a fresh issue of up to Rs.10,600 million and an offer for sale of up 6,300,000 equity shares. Price range for the offer has been fixed at Rs 695 – 720 per share.
Glenmark Life Sciences IPO Subscription Status Live
Day | Date | QIB | NII | Retail | Total |
Day 1 | 27-Jul-2021 17:00 | 0.00x | 0.85x | 5.17x | 2.78x |
Day 2 | 28-Jul-2021 17:00 | 1.38x | 3.39x | 9.28x | 5.78x |
Day 3 | 29-Jul-2021 17:00 | 36.96x | 122.54x | 14.63x | 44.17x |
About Glenmark Life Sciences
Glenmark Life Science is the leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (“APIs”) in chronic therapeutic areas, including cardiovascular disease (“CVS”), central nervous system disease (“CNS”), pain management and diabetes.
Glenmark Life Sciences IPO Price – Details
Description | GLS IPO Details |
---|---|
Public Issue | Initial Public offer of [.] Equity Shares aggregating upto Rs.[.] million comprising a Fresh Issue of up to Rs. 10,600 million and an Offer for Sale of up to 6,300,000 equity shares |
Issue Open Date | 27-Jul-21 |
Issue Close Date | 29-Jul-21 |
Issue Type | Book Built |
IPO Price Band | ₹ 695 to ₹ 720 per equity share |
Face Value | ₹ 2 |
Market Lot | 20 Equity Shares and in multiples thereof |
Minimum Order Quantity | 20 Equity Shares |
Maximum Subscription Amount for Retail Investor | Rs. 2,00,000 |
Listing | BSE, NSE |
NSE Symbol | GLS |
IPO Market Timings | 10.00 a.m. to 5.00 p.m. |
GLS IPO Subscription Status – FAQs
How much Glenmark Life Sciences IPO subscribed on Day 3?
The Glenmark Life Sciences IPO subscribed 44.17 times on day 3
How much Glenmark Life Sciences IPO subscribed on Day 2?
The Glenmark Life Sciences IPO subscribed 5.78 times on day 2.
How much Glenmark Life Sciences IPO retail subscription on Day 1 ?
The Glenmark Life Sciences IPO retail subscription is 2.78 times on day 1
Follow us on Telegram for all latest updates